Decheng Capital Management Iii (Cayman), LLC Aura Biosciences, Inc. Transaction History
Decheng Capital Management Iii (Cayman), LLC
- $181 Million
- Q3 2023
A detailed history of Decheng Capital Management Iii (Cayman), LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Decheng Capital Management Iii (Cayman), LLC holds 1,163,123 shares of AURA stock, worth $8.55 Million. This represents 5.77% of its overall portfolio holdings.
Number of Shares
1,163,123
Previous 293,333
296.52%
Holding current value
$8.55 Million
Previous $3.62 Million
188.05%
% of portfolio
5.77%
Previous 1.92%
Shares
3 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
39.9MCall Options Held
400Put Options Held
1.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$50.9 Million0.5% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$42.6 Million0.73% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.47MShares$32.8 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.68MShares$27 Million0.01% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$22.3 Million6.26% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $215M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...